Health Catalyst (HCAT) Depreciation & Amortization (CF) (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $12.1 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 1.66% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.3 million (up 16.35% YoY) and the FY2025 annual result came in at $50.5 million, up 21.89% from the prior year.
• Depreciation & Amortization (CF) eased to $12.1 million in Q1 2026, from $12.9 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $12.9 million in Q4 2025 to a low of $10.0 million in Q3 2024.
• A 5-year average of $11.4 million and a median of $11.6 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 54.96% — and 2023, when it dropped 17.64%.
• Tracing HCAT's Depreciation & Amortization (CF) over 5 years: stood at $11.7 million in 2022, then slipped by 11.66% to $10.3 million in 2023, then slipped by 0.37% to $10.3 million in 2024, then advanced by 25.48% to $12.9 million in 2025, then declined by 5.95% to $12.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $12.1 million (Q1 2026), $12.9 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.